Back to Dividend Stocks
Abbott Laboratories (ABT) logo

Abbott Laboratories

Dividend AristocratS&P 500
ABT|Healthcare|Medical Devices|$84.32|P/E 23.6|MCap 146.9B|NYSE

Last update: May 9, 2026 at 09:32

Dividend Safety Rating

82/ 100Very Safe

ABT's dividend appears very safe. Strengths include a 67.2% earnings payout ratio & 56.8% fcf payout ratio. Areas of concern: Volatile profit margin stability. As a Dividend Aristocrat with 25+ consecutive years of increases, ABT has a proven commitment to shareholders.

Based on 15 of 15 metrics

Strengths

  • Interest Coverage: 18.2xEarnings cover interest payments many times over.
  • Net Debt / Total Assets: 6.2%Healthy balance sheet with low net debt.
  • Gross Margin: 56.2%High gross margin signals strong pricing power.

Risks

  • Profit Margin Stability: VolatileProfit margins have been volatile.

Payout & Coverage

Safe
Earnings Payout Ratio
67.2%Safe
FCF Payout Ratio
56.8%Safe
CFO Payout Ratio
38.1%Safe
Interest Coverage
18.2xVery Safe

Balance Sheet

Safe
Net Debt / Total Assets
6.2%Very Safe
Current Ratio
1.4xCaution
Debt-to-Equity
64.8Safe

Profitability

Safe
Return on Equity
12.3%Safe
Operating Margin
13.5%Caution
Gross Margin
56.2%Very Safe
Profit Margin Stability
VolatileWarning

Dividend Track Record

Very Safe
Dividend Streak
Aristocrat (25+ yrs)Very Safe
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
10.4%Very Safe
Earnings Stability
GrowingVery Safe

About Abbott Laboratories

Abbott Laboratories is a diversified global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of health care products worldwide. It operates across four key segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, addressing needs from chronic disease management to acute diagnostics. The company offers generic pharmaceuticals treating conditions such as pancreatic exocrine insufficiency, irritable bowel syndrome, dyslipidemia, hypertension, hypothyroidism, pain, fever, inflammation, and migraine, alongside anti-infectives, influenza vaccines, and gastrointestinal regulators. Notable products include cardiovascular devices like pacemakers and stents, diabetes management tools such as continuous glucose monitors, pediatric and adult nutritional formulas, and advanced diagnostic equipment like immunoassays and point-of-care testing kits. With approximately 114,000 employees and a history dating back to 1888, Abbott Laboratories generates the majority of its sales outside the United States, playing a pivotal role in advancing medical innovation, improving patient outcomes, and supporting global health initiatives through its extensive reach in consumer, institutional, and professional markets.

Dividend Overview

Dividend Yield

2.89%

Annual Dividend

$2.44

Frequency

Quarterly

Payout Ratio

67.23%

FCF Payout Ratio

56.76%

Stock Price

$84.32

52-Week Range

$84.08 $139.06

Dividend History (2016–2025)

ABT annual dividend per share and yield history

Earnings & Profitability

ABT earnings per share and net profit margin

Key Dates

Last Ex-Dividend Date

April 15, 2026

Next Payment Date

May 15, 2026

Dividend Growth

3-Year Dividend CAGR

7.87%

5-Year Dividend CAGR

10.38%

10-Year Dividend CAGR

9.41%

3-Year Total Growth

25.53%

5-Year Total Growth

63.89%

10-Year Total Growth

145.83%

Dividend Aristocrat (25+ yrs)

This company has increased its dividend for 25+ consecutive years.

Income Calculator

ABT Dividend Calculator

Total Investment

$8,432.00

Annual Income

$244.00

Quarterly Income

$61.00

Monthly Income

$20.33

Similar Dividend Stocks

StockYield5Y CAGRPrice
Abbott Laboratories (ABT) logo
ABT
2.89%10.38%$84.32
Boston Scientific Corporation (BSX) logo
BSX
0.00%N/A$53.93
Gilead Sciences Inc. (GILD) logo
GILD
2.43%3.04%$131.33
Intuitive Surgical, Inc. (ISRG) logo
ISRG
0.00%N/A$450.06
Medtronic plc (MDT) logo
MDT
3.73%4.42%$76.15
Merck & Co., Inc. (MRK) logo
MRK
2.98%6.75%$111.38
Stryker Corporation (SYK) logo
SYK
1.21%7.62%$285.47
Thermo Fisher Scientific Inc. (TMO) logo
TMO
0.38%14.34%$465.00
UnitedHealth Group Incorporated (UNH) logo
UNH
2.33%12.57%$379.98

Frequently Asked Questions

What is ABT's current dividend yield?
Abbott Laboratories (ABT) currently has a dividend yield of 2.89%, based on a stock price of $84.32 and an annual dividend of $2.44.
When is ABT's next dividend payment date?
ABT's next ex-dividend date is 2026-04-15 and the next payment date is 2026-05-15. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does ABT pay in dividends per year?
Abbott Laboratories paid $2.36 per share in annual dividends in 2025. The dividends are paid quarterly.
Has ABT been increasing its dividend?
Yes, Abbott Laboratories is a Dividend Aristocrat (25+ yrs). Its dividend has grown at a 5-year CAGR of 10.38%, a 3-year CAGR of 7.87% and a 10-year CAGR of 9.41%.
Is ABT's dividend safe?
Abbott Laboratories has a payout ratio of 67.23%. Its free cash flow payout ratio is 56.76%. The payout ratio is moderate. Monitor earnings to ensure sustainability.
How is ABT's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Abbott Laboratories's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track ABT Dividends with OnlyDividends

What will ABT actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.